Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colorectal Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07377487
What this trial is testing

TheraSphere Japan Pre-Market Study

Who this might be right for
Liver Neoplasms
Boston Scientific Corporation 51
Testing effectiveness (Phase 2)Study completedNCT04208958
What this trial is testing

Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer

Who this might be right for
Metastatic CancerMelanomaGastric Cancer+2 more
Vedanta Biosciences, Inc. 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT05627635
What this trial is testing

FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal AdenocarcinomaMetastatic Microsatellite Stable Colorectal Carcinoma+4 more
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT01263171
What this trial is testing

Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery

Who this might be right for
Colorectal Cancer
Cardiff University 60
Early research (Phase 1)Study completedNCT02903914
What this trial is testing

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorsColorectal Cancer (CRC)+7 more
Incyte Corporation 260
Early research (Phase 1)Study completedNCT00059930
What this trial is testing

Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT00004860
What this trial is testing

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)WithdrawnNCT06707896
What this trial is testing

TCR1020-CD8 T Cells in KRAS-mutated Cancers

Who this might be right for
Metastatic Pancreatic AdenocarcinomaColorectal Cancer
University of Pennsylvania
Early research (Phase 1)Ended earlyNCT00937482
What this trial is testing

Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Male Breast CancerStage IV Breast CancerStage IV Melanoma+7 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Ended earlyNCT03422679
What this trial is testing

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Who this might be right for
Breast CancerColorectal CancerAdenoid Cystic Carcinoma+5 more
Cellestia Biotech AG 79
Not applicableActive Not RecruitingNCT02874885
What this trial is testing

Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal AdenocarcinomaMetastatic Rectal AdenocarcinomaRectosigmoid Adenocarcinoma+10 more
M.D. Anderson Cancer Center 341
Testing effectiveness (Phase 2)UnknownNCT02959151
What this trial is testing

Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy

Who this might be right for
Carcinoma, HepatocellularPancreatic Cancer MetastaticColorectal Cancer Metastatic
Shanghai GeneChem Co., Ltd. 20
Large-scale testing (Phase 3)Ended earlyNCT00070122
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI) 2,200
Large-scale testing (Phase 3)UnknownNCT00482222
What this trial is testing

Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University of Southampton 340
Testing effectiveness (Phase 2)Looking for participantsNCT06640166
What this trial is testing

Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.

Who this might be right for
Colorectal CarcinomaColorectal NeoplasmsColorectal Tumor+7 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 25
Large-scale testing (Phase 3)Study completedNCT00623805
What this trial is testing

Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 123
Early research (Phase 1)Looking for participantsNCT05856981
What this trial is testing

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultMetastatic Solid TumorRefractory Cancer+4 more
Sairopa B.V. 130
Large-scale testing (Phase 3)Active Not RecruitingNCT02997228
What this trial is testing

Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study

Who this might be right for
Metastatic Colorectal AdenocarcinomaStage IV Colorectal Cancer AJCC v7
National Cancer Institute (NCI) 120
Testing effectiveness (Phase 2)Looking for participantsNCT07201519
What this trial is testing

Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy

Who this might be right for
Colorectal Cancer MetastaticIntrahepatic Cholangiocarcinoma
Michael J Cavnar, MD 80
Testing effectiveness (Phase 2)Study completedNCT01289821
What this trial is testing

First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib

Who this might be right for
Colorectal Neoplasms
Bayer 54
Next Page